In vivo xenograft model revealed that the shRPA1 xenografts with RPA1 knockdown cells had reduced tumor volume and weight, as compared to the control group, indicating that the knockdown of RPA1 significantly inhibited orthotopic tumor formation of NPC cells in mice (Figure 3F). This evidence concerns the gene RPA1 and nasopharyngeal carcinoma.